All Stories

  1. The neglected PCK1/glucagon (inter)action in nutrient homeostasis beyond gluconeogenesis: Disease pathogenesis and treatment
  2. Chitosan Microparticles Enhance the Intestinal Release and Immune Response of an Immune Stimulant Peptide in Oncorhynchus mykiss
  3. LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects
  4. Is IIIG9 a New Protein with Exclusive Ciliary Function? Analysis of Its Potential Role in Cancer and Other Pathologies
  5. Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients
  6. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients
  7. Dehydroascorbic acid, the oxidized form of vitamin C, improves renal histology and function in old mice
  8. Cytosolic phosphoenolpyruvate carboxykinase is expressed in α‐cells from human and murine pancreas
  9. Gluconeogenic Enzymes in β-Cells: Pharmacological Targets for Improving Insulin Secretion
  10. Sodium tungstate: Is it a safe option for a chronic disease setting, such as diabetes?
  11. The Antidiabetic Agent Sodium Tungstate Induces Abnormal Glycogen Accumulation in Renal Proximal Tubules from Diabetic IRS2-Knockout Mice
  12. SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain Pathologies
  13. Aging Selectively Modulates Vitamin C Transporter Expression Patterns in the Kidney
  14. Sodium tungstate mimics insulin effect on nuclear translocation of FBPase in rat liver
  15. Apical Polarization of SVCT2 in Apical Radial Glial Cells and Progenitors During Brain Development
  16. Is the anti-diabetic agent sodium tungstate an anti-inflammatory factor?
  17. SGLT2 Inhibitors: Glucotoxicity and Tumorigenesis Downstream the Renal Proximal Tubule?
  18. SVCT2 Overexpression in Neuroblastoma Cells Induces Cellular Branching that is Associated with ERK Signaling
  19. In vivo sodium tungstate treatment prevents E-cadherin loss induced by diabetic serum in HK-2 cell line
  20. Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans
  21. Over-expression of muscle glycogen synthase in human diabetic nephropathy
  22. Fructose 1,6-bisphosphatase and aldolase B location in organs of sheep supplemented with nonprotein nitrogen
  23. Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney
  24. Non-protein nitrogen supplementation increases gluconeogenic capacity in sheep
  25. Dynamic expression of the sodium-vitamin C co-transporters, SVCT1 and SVCT2, during perinatal kidney development
  26. Nuclear accumulation of fructose 1,6-bisphosphatase is impaired in diabetic rat liver
  27. Expression of key substrate cycle enzymes in rat spermatogenic cells: Fructose 1,6 bisphosphatase and 6 phosphofructose 1-kinase
  28. Novel expression of liver FBPase in Langerhans islets of human and rat pancreas
  29. Subcellular localization of liver FBPase is modulated by metabolic conditions
  30. Different involvement for aldolase isoenzymes in kidney glucose metabolism: Aldolase B but not aldolase A colocalizes and forms a complex with FBPase
  31. Nuclear localization of liver FBPase isoenzyme in kidney and liver
  32. Broad expression of fructose-1,6-bisphosphatase and phosphoenolpyruvate carboxykinase provide evidence for gluconeogenesis in human tissues other than liver and kidney